• 1. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 2. Excited state character of Cibalackrot-type compounds interpreted in terms of Hückel-aromaticity: a rationale for singlet fission chromophore design?
  Weixuan Zeng,Ouissam El Bakouri,Henrik Ottosson Chem. Sci., 2021,12, 6159-6171
• 3. Feasibility of polyethylene composites reinforced by distillers dried fibers with solubles (DDFS) after different generations of ethanol fermentation?
  Bo Chen,Xiaotong Shen,Zhangfeng Luo,Di Cai,Changjing Chen,Changwei Zhang,Peiyong Qin,Hui Cao,Tianwei Tan RSC Adv., 2018,8, 25602-25610
• 4. ETFE-based anion-exchange membrane ionomer powders for alkaline membrane fuel cells: a first performance comparison of head-group chemistry?
  Lianqin Wang,Rachida Bance-Soualhi,Julia Ponce-González,Pilar Ocón,Edson A. Ticianelli,Daniel K. Whelligan,John R. Varcoe J. Mater. Chem. A, 2018,6, 24330-24341
• 5. Exfoliation of transition-metal dichalcogenides using ATP in aqueous solution?
  Xinyi Liu,Huan Chen,Jing Lin,Yi Li,Liangqia Guo Chem. Commun., 2019,55, 2972-2975

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Fluorobenzenes

Introduction to 2-(2-Chloro-4-fluorophenyl)acetic Acid (CAS No. 177985-32-9)

2-(2-Chloro-4-fluorophenyl)acetic acid (CAS No. 177985-32-9) is a versatile organic compound that has gained significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, often referred to as CFAA, is characterized by its unique structural features, including a chloro and fluoro substituent on the phenyl ring, which contribute to its distinct chemical and biological properties.

The molecular formula of 2-(2-chloro-4-fluorophenyl)acetic acid is C₉H₇ClF₂O₂, and it has a molecular weight of approximately 205.6 g/mol. The presence of the chlorine and fluorine atoms imparts significant electronic and steric effects, making this compound a valuable building block in the synthesis of various pharmaceuticals and agrochemicals.

In recent years, CFAA has been extensively studied for its potential applications in drug discovery and development. One of the key areas of interest is its role as an intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs), which are widely used in the treatment of depression and anxiety disorders. The unique substituents on the phenyl ring enhance the compound's ability to interact with specific receptors, thereby improving its pharmacological profile.

Beyond its use in SSRI synthesis, 2-(2-chloro-4-fluorophenyl)acetic acid has also shown promise in the development of novel anti-inflammatory agents. Research published in the Journal of Medicinal Chemistry highlights its potential as a lead compound for designing drugs that target inflammatory pathways. The compound's ability to modulate key enzymes involved in inflammation, such as cyclooxygenase (COX), makes it an attractive candidate for further investigation.

The synthetic route to CFAA involves several well-established chemical transformations. One common method involves the reaction of 2-chloro-4-fluorobenzaldehyde with acetic acid followed by reduction to form the desired product. This synthetic pathway is highly efficient and scalable, making it suitable for industrial production. Additionally, recent advancements in green chemistry have led to the development of more environmentally friendly methods for synthesizing this compound, further enhancing its appeal in both academic and industrial settings.

In terms of physical properties, 2-(2-chloro-4-fluorophenyl)acetic acid is a white crystalline solid with a melting point ranging from 105°C to 107°C. It is soluble in common organic solvents such as ethanol, methanol, and dichloromethane but has limited solubility in water. These properties make it easy to handle and process in laboratory and industrial environments.

The safety profile of CFAA is another important consideration for its use in pharmaceutical applications. Extensive toxicological studies have shown that it exhibits low toxicity when used at appropriate concentrations. However, like many organic compounds, it should be handled with care to avoid prolonged exposure or inhalation. Proper safety measures, including the use of personal protective equipment (PPE), are recommended when working with this compound.

In conclusion, 2-(2-chloro-4-fluorophenyl)acetic acid (CAS No. 177985-32-9) is a multifunctional compound with significant potential in various areas of medicinal chemistry and pharmaceutical research. Its unique structural features and favorable chemical properties make it an essential building block for the synthesis of important therapeutic agents. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in the development of innovative treatments for a wide range of diseases.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)